Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan Axelrad

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Journal of Crohn'S & Colitis|December 15, 2025
Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: A nationwide cohort studyJordan Axelrad, Anders Forss, Jonas Söderling, et al.
Digestive Diseases and Sciences|August 7, 2023
Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn's DiseaseTerry Li, Benjamin Click, Salam Bachour, et al.
Alimentary Pharmacology & Therapeutics|October 22, 2025
Treatment-Free Outcomes Following Surgery for IBD: A Nationwide Cohort StudyAdam S Faye, Jordan Axelrad, Jiangwei Sun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2026
Incidence and risk of colorectal dysplasia in patients with inflammatory bowel disease: A nationwide cohort studyJordan Axelrad, Adam S Faye, Jonas Söderling, et al.
Clinical Colorectal Cancer|October 16, 2016
Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel DiseaseJordan Axelrad, Anuja Kriplani, Umut Ozbek, et al.
Eclinicalmedicine|December 5, 2022
Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes: A nationwide studyKarl Mårild, Jonas Söderling, Olof Stephansson, et al.
JMIR Research Protocols|December 15, 2022
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled TrialJordan Axelrad, Millie Long, Sara Horst, et al.
Inflammatory Bowel Diseases|August 15, 2020
Prevalence, Predictors, and Disease Activity of Sacroiliitis Among Patients with Crohn's DiseaseIrving Levine, Fardina Malik, Gabriel Castillo, et al.
Gastroenterology|February 8, 2024
Histologic Remission in Inflammatory Bowel Disease and Female Fertility: A Nationwide StudyKarl Mårild, Jonas Söderling, Olof Stephansson, et al.
Inflammatory Bowel Diseases|October 22, 2024
GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBDIrving Levine, Shaina Sekhri, William Schreiber-Stainthorp, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Journal of Crohn'S & Colitis|December 15, 2025
Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: A nationwide cohort studyJordan Axelrad, Anders Forss, Jonas Söderling, et al.
Digestive Diseases and Sciences|August 7, 2023
Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn's DiseaseTerry Li, Benjamin Click, Salam Bachour, et al.
Alimentary Pharmacology & Therapeutics|October 22, 2025
Treatment-Free Outcomes Following Surgery for IBD: A Nationwide Cohort StudyAdam S Faye, Jordan Axelrad, Jiangwei Sun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2026
Incidence and risk of colorectal dysplasia in patients with inflammatory bowel disease: A nationwide cohort studyJordan Axelrad, Adam S Faye, Jonas Söderling, et al.
Clinical Colorectal Cancer|October 16, 2016
Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel DiseaseJordan Axelrad, Anuja Kriplani, Umut Ozbek, et al.
Eclinicalmedicine|December 5, 2022
Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes: A nationwide studyKarl Mårild, Jonas Söderling, Olof Stephansson, et al.
JMIR Research Protocols|December 15, 2022
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled TrialJordan Axelrad, Millie Long, Sara Horst, et al.
Inflammatory Bowel Diseases|August 15, 2020
Prevalence, Predictors, and Disease Activity of Sacroiliitis Among Patients with Crohn's DiseaseIrving Levine, Fardina Malik, Gabriel Castillo, et al.
Gastroenterology|February 8, 2024
Histologic Remission in Inflammatory Bowel Disease and Female Fertility: A Nationwide StudyKarl Mårild, Jonas Söderling, Olof Stephansson, et al.
Inflammatory Bowel Diseases|October 22, 2024
GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBDIrving Levine, Shaina Sekhri, William Schreiber-Stainthorp, et al.
Pageof 7